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1726-4ReplyDear Editor,
We thank Joob and Wiwanitkit1 for their interest in our
recent work2 and their insightful comments. We are grateful for
the opportunity to respond. Liang et al3 conducted a nation-
wide population-based study and showed that the incidence of
peptic ulcer disease in the general population was between 1.1
per 1000 persons and 2.0 per 1000 persons per year. The
incidence in patients with chronic kidney disease increased
from 13.2 per 1000 persons to 19.8 per 1000 persons per year
over that time, and the incidence was 10e12 times higher than
that in patients without chronic kidney disease over a 10-year
period. End-stage renal disease patients exhibit a higher inci-
dence of peptic ulcer disease than patients without renal dis-
ease.4 However, our aims differed from those of Liang et al.3
Factors such as reductions in mucosa prostaglandin,4 hyper-
gastrinemia,5 drugs such as nonsteroidal anti-inflammatory
drugs,6 and systemic/local circulatory failure7 influence the
onset of peptic ulcer disease in end-stage renal disease patients.
Establishing the reliability of diagnostic methods for Heli-
cobacter pylori (H. pylori) is important for managing infection.
The approach of combining all techniques has been used in
previous studies evaluating the diagnostic method for H. pylori
infection.8e10 However, we used the data obtained from the
Taiwan National Health Insurance Research database; this
“gold standard” of combining all techniques was not reim-
bursed by the Taiwan National Health Insurance. We agree on
the limitations of false-negative and false-positive rates in our
current study. A study by Calvet et al11 showed that higher
sensitivity and specificity can be obtained by using rapid ure-
ase test and histological examination. The false-negative and
false-positive rates are, respectively, about 5.31% (6/113) and
0% (0/86) using a rapid urease test, and 6.19% (7/113) and
1.16% (1/86) with a histological examination, according to the
study of Calvet et al.11 In addition, Neithercut et al12 used the
urea:ammonium ratio to prove the presence of H. pylori
infection in patients with chronic renal failure, and one case (1/
23) of false positive result can still be seen in the study. The
focus of our future research will likely be to evaluate the effect
of H. pylori eradication on the recurrence of complicated
peptic ulcer disease in early end-stage renal disease patients.x.doi.org/10.1016/j.jcma.2014.09.001
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